{"name":"Nature Cell Co. Ltd.","slug":"nature-cell-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AstroStem","genericName":"AstroStem","slug":"astrostem","indication":"Treatment of ischemic stroke","status":"phase_2"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Synvisc-One","genericName":"Synvisc-One","slug":"synvisc-one","indication":"Osteoarthritis of the knee","status":"marketed"}]}],"pipeline":[{"name":"AstroStem","genericName":"AstroStem","slug":"astrostem","phase":"phase_2","mechanism":"AstroStem is a stem cell therapy that aims to repair damaged tissues and promote regeneration.","indications":["Treatment of ischemic stroke"],"catalyst":""},{"name":"Synvisc-One","genericName":"Synvisc-One","slug":"synvisc-one","phase":"marketed","mechanism":"Synvisc-One is a hyaluronic acid-based viscosupplement that lubricates and cushions the knee joint to reduce pain and improve mobility in osteoarthritis.","indications":["Osteoarthritis of the knee"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBzeWM3YW1xUnprdWJ0cEpCSmJ3d21VUlAwRERRUTJ4LXplTGVNRk5OMWZKQ2FFcFRvRkw3aVFucVp0WXJKSV96T2ppSldYaTFJSXltYk1FdmhMczFRcmdZ?oc=5","date":"2026-02-23","type":"regulatory","source":"nature.com","summary":"First-of-a-kind stem-cell therapies set for approval in Japan - nature.com","headline":"First-of-a-kind stem-cell therapies set for approval in Japan","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4xMHVKU1RITHdrZjVaUW1md05BUnU3UzhLMG82YXJHUWtDYnpMTDFEU051UjVWVlFDLTcyb3dpQTZQcTVnempQbmM0ekhjeVBPVlp2NDJyMHl1QllIR3ZF?oc=5","date":"2026-01-13","type":"trial","source":"nature.com","summary":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson - nature.com","headline":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9JaHJ0WExWNW9lS2dQX3VfcnYtWGpoQldNT3FPMWQwdnpXMkJFYldtMk14TUhSM3M1OWVldVBPejBpV2J5VjJ2UEpFLWNEeHdtMnB2RjVyUndVOWgwNkcw?oc=5","date":"2025-12-09","type":"pipeline","source":"nature.com","summary":"Turning award-winning science into therapies - nature.com","headline":"Turning award-winning science into therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TNmZmUnhPRXVHRjB0Q0MwSmFuWk13MXdGREx1UV9MOWhZYjQ2WDVzNmJJcWVvNExncUxPN0FZTVZtMXVQTFM0VUo0R08xczdiUzdUUy1WM01nclB2TC1v?oc=5","date":"2025-09-22","type":"pipeline","source":"nature.com","summary":"Comparative single-cell and spatial profiling of anti-SSA-positive and anti-centromere-positive Sjögren’s disease reveals common and distinct immune activation and fibroblast-mediated inflammation - n","headline":"Comparative single-cell and spatial profiling of anti-SSA-positive and anti-centromere-positive Sjögren’s disease reveal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5wcDVMa0M2cURfLXo3TVB1SFVLc2tBa3VlOTdHdzJvMlc3ZVpQT2tMU242aTFNdDFKSFMzRkJNeUg0UUxmc21aWXBQVmZ5cHhFdWtQdGpPRjVwVGp4Yk5R?oc=5","date":"2025-07-21","type":"pipeline","source":"nature.com","summary":"The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation - nature.com","headline":"The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5Hc2twLUtwLWpkU0FkTVZhNzlqZEhuQS0wVm9qTUN5ckQ4bWVYSWZpQVdqWXlhNnFSVWxIalhtZ21NUDRhME5YNmNMOHZYa0ZHa2lsa0E1SFplZWZUWkJj?oc=5","date":"2025-07-01","type":"pipeline","source":"nature.com","summary":"Bioengineered chondrocyte-products from human induced pluripotent stem cells are useful for repairing articular cartilage injury in minipig model - nature.com","headline":"Bioengineered chondrocyte-products from human induced pluripotent stem cells are useful for repairing articular cartilag","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE81TlpfZ2UwdlJRd1kzaWtneHJmTmZCeWhDTUJRVHB4eU5Sa3ZpZmdFd0RZR0ZqWGJmUjNHSmtBY3ZjM0piTm82ODRzZWlQd2I4MFZqUEFoUHU4ZWZIMUo0?oc=5","date":"2025-06-17","type":"pipeline","source":"nature.com","summary":"Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis - nature.com","headline":"Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4tUXJrWVliWHFQQmtJZFB6dUJuYTlEUnJ6RTVMT0VtRHduNlpKT1c5SGY3M1c0OUlIWEZhRjEtbkJEZ2RrU0VjUzdmbjd6b2c0RnY0NmFlSlJtTmFLTlNn?oc=5","date":"2025-05-21","type":"trial","source":"nature.com","summary":"Retrospective database study of druggable mutation detection among patients with non-small cell lung cancer in Japan - nature.com","headline":"Retrospective database study of druggable mutation detection among patients with non-small cell lung cancer in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE16Sm5pRWRrQTdFWjQ3bDVMbVlCRkdsOXJITHk4bl9MMXFmQ0VqalgwY05ZVkR5c0NzSW1kUEx1WGVkZ1NtLVNUYk94WHdCc09XWW15aEp0dTBhN21KcEhB?oc=5","date":"2025-04-25","type":"pipeline","source":"nature.com","summary":"Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malignant lymphoma - nature.com","headline":"Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malign","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQeEpkeGlXYXZjVUw0cDFyOHNjclBMZ21EaUNvN3NJYlhSMm0wVEF4Z1dUVzBIZlBlRFFxMG1heUF4RF9NTmpYeHc2ejZwOTdlOWxScFdRQlRhcThNbkFlY3hweFdnTVhQeHJXVDVPNGkwOWg2YThVcklORVlwdjlUOXhKSzFJVV9yWGd2czc4eDhSV0FKeUZ3WXB1Q3dNemp2V1NEWTFZeHdjV0JQUG5CdQ?oc=5","date":"2025-04-17","type":"pipeline","source":"Bloomberg.com","summary":"Sumitomo Pharma Poised to Jump on Stem Cell Research Results - Bloomberg.com","headline":"Sumitomo Pharma Poised to Jump on Stem Cell Research Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE53ZzFJSXVpaHlrdXcxV2RwWDBUbWZ2a0lPUHRoMmZxNHcxMFE2cC1feXU0YUYyQTR3dTBycVRKeDZCU0NlMG5LbHZzSU02cS1ZaWI5VGhmM2FBWDZON01J?oc=5","date":"2024-03-13","type":"pipeline","source":"nature.com","summary":"Translating basic research into medical advances - nature.com","headline":"Translating basic research into medical advances","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE05Z0l6djk0UXowYXZQaUQzVEZCOExDRHVKZENTcFRjZlJxWW1xVjhJOUlOUkxYTVNfeVJBVEZmU2g3Z0NYSUlLaWg5WGE2VzBoakd5dnp0QWFra3pkeGtn?oc=5","date":"2023-11-16","type":"pipeline","source":"nature.com","summary":"Pharma spends big to access key cell and gene therapy assets - nature.com","headline":"Pharma spends big to access key cell and gene therapy assets","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}